LGND Total Liabilities
Ligand Pharmaceuticals Inc · Total Liabilities
LGND Total Liabilities
Latest reported$543.43Mperiod ending
LGND FY Total Liabilities ($20.40M → $543.43M)
Annual total liabilities
High-resolution chart · PNG
LGND total liabilities history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Liabilities (USD) |
|---|---|
| 543,425,000 | |
| 111,335,000 | |
| 86,303,000 | |
| 165,183,000 | |
| 476,431,000 | |
| 652,760,000 | |
| 727,683,000 | |
| 699,889,000 | |
| 252,374,000 | |
| 230,732,000 | |
| 229,538,000 | |
| 233,621,000 | |
| 55,100,000 | |
| 77,775,000 | |
| 113,704,000 | |
| 82,550,000 | |
| 109,955,000 | |
| 181,813,000 | |
| 144,163,000 | |
| 298,701,000 | |
| 425,038,000 | |
| 407,783,000 | |
| 230,527,000 | |
| 196,594,000 | |
| 175,348,000 | |
| 168,547,000 | |
| 160,200,000 | |
| 167,400,000 | |
| 73,100,000 | |
| 67,600,000 | |
| 65,500,000 | |
| 20,400,000 |